0001193125-12-411417.txt : 20121001 0001193125-12-411417.hdr.sgml : 20121001 20121001164559 ACCESSION NUMBER: 0001193125-12-411417 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120928 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20121001 DATE AS OF CHANGE: 20121001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gevo, Inc. CENTRAL INDEX KEY: 0001392380 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 870747704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35073 FILM NUMBER: 121120414 BUSINESS ADDRESS: STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C STREET 2: Suite 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 303-858-8358 MAIL ADDRESS: STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C STREET 2: Suite 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: Gevo Inc DATE OF NAME CHANGE: 20070307 8-K 1 d418856d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 28, 2012

 

 

Gevo, Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-35073   87-0747704

(State or Other Jurisdiction of

Incorporation)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

345 Inverness Drive South, Building C, Suite 310, Englewood, CO 80112

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (303) 858-8358

N/A

(Former Name, or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) Departure of Named Executive Officer.

On October 1, 2012, Gevo, Inc. (the “Company”) announced that David Glassner, Ph.D., Executive Vice President of Technology, has left the Company effective September 28, 2012. In connection with his separation, Dr. Glassner will receive severance compensation and benefits consistent with the terms described in his previously disclosed employment agreement. Dr. Glassner was a “named executive officer” in the Company’s most recent proxy statement. Christopher Ryan, Ph.D., President and Chief Operating Officer has assumed the additional role of Chief Technology Officer.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Gevo, Inc.
By:  

/s/ Brett Lund

  Brett Lund
  Executive Vice President, General Counsel & Secretary

Date: October 1, 2012